GlassScriptPhysician profile
Harish Tummala
NPI 1023632098
$3,194.31
in general payments reported to CMS, 2019-2025
9 companies · $1,766 in 2025
The $1,766 reported for 2025 was more than what 91% of Oral and Maxillofacial Surgery providers received nationally (typical 2025 total: $150).
See the full distribution for Oral and Maxillofacial Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $102 · 2022: $22.90 · 2023: $507 · 2024: $666 · 2025: $1,766.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,289 · Travel and Lodging: $650.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,289.04 |
| Travel and Lodging | $649.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $947.50 | 2023-2025 | Tmj System, Traumaone, Ribfix Titan |
| Axogen | $867.52 | 2021-2025 | Avance Nerve Graft, Axoguard Nerve Connector, Axoguard Nerve Protector |
| Depuy Synthes Sales INC. | $519.51 | 2022-2025 | Trumatch, Matrixorthognathic, Na |
| Stryker Corporation | $347.87 | 2021-2025 | Vsp System, Vsp Cranial, Na |
| Smith+Nephew, INC. | $222.55 | 2023 | Stravix Pl |
| Acera Surgical, INC. | $130.32 | 2020 | |
| Kerecis Limited | $79.93 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Biohorizons Implant Systems INC. | $60.50 | 2023 | Biohorizons |
| Solventum Corporation | $18.61 | 2025 | Prevena |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Harish Tummala listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.